gougerotin

Known as: N(4)-sarcosyl-1-(3'-deoxy-3'-D-serylamido-beta-D- allopyranosyluronamide)cytosine, aspiculamycin, asteromycin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2005

2005

An efficient synthesis of gougerotin and related analogues using solid- and solution-phase methodology.

The first solid-phase synthesis of the natural product gougerotin has been accomplished. The synthetic route is versatile and…

1986

1986

Increased sensitivity of virus-infected cells to inhibitors of protein synthesis does not correlate with changes in plasma membrane permeability.

1979

1979

The cross-resistance of mouse blasticidin S-resistant cell lines to puromycin and sparsomycin, inhibitors of ribosome function.

1974

1974

Enhancement of rat liver uridine kinase activity by various metabolic inhibitors.

1972

1972

An antimycoplasma antibiotic asteromycin: its identity with gougerotin.

Sir: Because of the high correlation between antitumor activity and antimycoplasma activity, we have been using a Mycoplasma…

1972

1972

The effect of antibiotics on the substrate binding to the acceptor and donor site of ribosomal peptidyltransferase of an erythromycin-resistant mutant of Escherichia coli.

1970

1970

Studies on the formation of transfer ribonucleic acid-ribosome complexes. IX. Effect of antibiotics on translocation and peptide bond formation.

1970

1970

FURTHER STUDIES ON THE EFFECTS OF BLOCKING AGENTS ON PROTEIN SYNTHESIS IN GOLDFISH BRAIN 1

Abstract— In further experiments on the effects of antibiotic agents on protein synthesis in the goldfish brain, doses of…

Highly Cited

1967

Highly Cited

1967

Reaction of ribosome-bound peptidyl transfer ribonucleic acid with aminoacyl transfer ribonucleic acid or puromycin.

Highly Cited

1967

Highly Cited

1967

Effects of some inhibitors of protein synthesis on the binding of aminoacyl tRNA to ribosomal subunits.